Isabelle Ricard

The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.

Richard Béliveau, Denis Gingras, Erwin A. Kruger et al. · PubMed · 2002 · 65 citations

New Insights into How Yersinia pestis Adapts to Its Mammalian Host during Bubonic Plague

Elizabeth Pradel, Nadine Lemaître, Maud Merchez et al. · PLoS Pathogens · 2014 · 56 citations · Full text

Easily synthesized antimalarial ferrocene triazacyclononane quinoline conjugates

Christophe Biot, Jean Dessolin, Isabelle Ricard et al. · Journal of Organometallic Chemistry · 2004 · 53 citations

Pharmacology, Synthetic Chemistry, Heterocyclic +1

Phenotypic analysis of Yersinia pseudotuberculosis 32777 response regulator mutants: New insights into two-component system regulon plasticity in bacteria

Claire Flamez, Isabelle Ricard, Sonia Arafah et al. · International Journal of Medical Microbiology · 2007 · 51 citations

Response Regulator Mutants, Phenotypic Analysis, Virulence Factor +9

VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its α4β1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes

Isabelle Ricard, Marcel D. Payet, Gilles Dupuis · European Journal of Immunology · 1998 · 46 citations · Full text